The retinohypothalamic tract (RHT) is the principal pathway mediating the entraining effects of light on the circadian pacemaker, the suprachiasmatic nucleus (SCN). In the rat, the RHT has two components, one which projects to the SCN and the intergeniculate leaflet of the thalamus and has no known peptide content and one which projects to the SCN and, perhaps, to the olivary pretectal nucleus and contains substance P (SP). Both terminate predominantly in a zone of the SCN that contains vasoactive intestinal polypeptide (VIP)-producing neurons. In the human, there is a similar dense axonal plexus of SP-immunoreactive axons in the SCN located largely in the area occupied by VIP-immunoreactive neurons and distinct from other SP-immunoreactive axons in the area. We propose that this SP plexus represents a component of the RHT in the human brain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0006-8993(94)90887-7DOI Listing

Publication Analysis

Top Keywords

projects scn
8
sp-immunoreactive axons
8
scn
5
putative retinohypothalamic
4
retinohypothalamic projection
4
projection substance
4
substance human
4
human retinohypothalamic
4
retinohypothalamic tract
4
tract rht
4

Similar Publications

Multi-omics analysis identified the GmUGT88A1 gene, which coordinately regulates soybean resistance to cyst nematode and isoflavone content.

Plant Biotechnol J

January 2025

Key Laboratory of Soybean Biology of Ministry of Education China, Key Laboratory of Soybean Biology and Breeding (Genetics) of Ministry of Agriculture and Rural Affairs, Northeast Agricultural University, Harbin, China.

Soybean cyst nematode (SCN, Heterodera glycines) is a major pathogen harmful to soybean all over the world, causing huge yield loss every year. Soybean resistance to SCN is a complex quantitative trait controlled by a small number of major genes (rhg1 and Rhg4) and multiple micro-effect genes. Therefore, the continuous identification of new resistant lines and genes is needed for the sustainable development of global soybean production.

View Article and Find Full Text PDF

Methicillin-resistant Staphylococcus aureus (MRSA) continues to pose significant challenges in healthcare settings due to its multi-drug resistance (MDR) and virulence. This retrospective study examines the molecular and resistance profiles of MRSA isolates from a tertiary care hospital in Saudi Arabia, providing valuable insights into regional epidemiology. A total of 190 MRSA strains were analysed to assess antimicrobial susceptibility, genetic diversity, and virulence factors.

View Article and Find Full Text PDF

Single-Cell RNA Sequencing Reveals the Developmental Landscape of Wheat Roots.

Plant Cell Environ

January 2025

State Key Laboratory for Biology of Plant Disease and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.

Allohexaploid wheat (Triticum aestivum L.) is one of the major crops worldwide, however there is very limited research on the transcriptional programmes of underlying cell type specification. Single-cell RNA sequencing (scRNA-seq) was used to unravel the transcriptome heterogeneity of cells and the composition of cell types in broad-spectrum organisms.

View Article and Find Full Text PDF

GD2-targeted theranostics of neuroblastoma with [Cu]Cu/[Lu]Lu-hu3F8.

Eur J Nucl Med Mol Imaging

December 2024

Department of Nuclear Medicine, Beijing Friendship Hospital Affiliated to Capital Medical University, 95 Yong'an Rd., Xicheng Dist, Beijing, 100050, China.

Purpose: Neuroblastoma (NB) is a malignant embryonic tumour with poor prognosis and high mortality rate. The antigen gisialoganglioside (GD2), which is highly expressed on the surface of NB cells, is an effective target for therapy. This study aims to evaluate the GD2 expression with [Cu]Cu-NOTA-hu3F8 positron emission tomography (PET) imaging and explore the radioimmunotherapy (RIT) effect of [Lu]Lu-DOTA-hu3F8 in NB tumour models.

View Article and Find Full Text PDF

Preclinical evaluation of 64Cu/177Lu-labelled anti-CD30 monoclonal antibody for theranostics in CD30-positive lymphoma.

Eur J Nucl Med Mol Imaging

December 2024

Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China.

Purpose: CD30 serves as an ideal therapeutic target for lymphoma, but its variable expression and high relapse rate pose challenges in targeted therapy. This study aims to label the anti-CD30 monoclonal antibody with Cu/Lu for immuno-positron emission tomography (immuno-PET) and radioimmunotherapy (RIT).

Methods: CD30 binding kinetics of anti-CD30-IgG (IMB16) were measured by Biolayer interferometry (BLI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!